IQVIA Holdings Inc.
NYSE:IQVMedical - Diagnostics & Research
-$3.13 today
- Market cap
- $42.49B
- Beta
- 1.22
- P/E (TTM)
- 20.4
- EPS (TTM)
- $8.22
Volume 1.40M
Average 1.62M
IQV EBITDA Margin
EBITDA as a percentage of revenue.
IQVIA Holdings Inc.NYSE: IQV
EBITDA Margin · Q2 FY2026 · quarter ended Jun 2026
EBITDA Margin narrows to 18.1%
EBITDA Margin was 18.1% in Q2 FY2026, down 1.4 pp from a year earlier. On a trailing-twelve-month basis it was 20.8%, down 0.6 pp year over year. Over 3 fiscal years it narrowed by 2.2 pp.
Context
- EBITDA Margin widened in 2 of the last 3 fiscal years.
- FY2025 was the lowest level in the 4 fiscal years shown.
What to watch
Whether EBITDA Margin reaches the consensus estimate from 14 analysts of 22.9% for the fiscal year ending Dec 2026, up from 18.0% in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterJun 2026
- 18.1%-1.4 pp QoQ
- Last fiscal yearDec 2025
- 18.0%-4.4 pp YoY
- LTMJun 2026
- 20.8%-0.6 pp YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | -1.4 pp | +5.1 pp | +6.5 pp |
| 1 year | -4.4 pp | +4.8 pp | +9.2 pp |
| 3 years | -2.2 pp | +4.9 pp | +7.1 pp |
| 5 years | +6.3 pp | — | |
| 10 years | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA Margin history
Percent of revenue · from the income statement
- Latest · FY2025
- 18.0%
- Year-over-year change
- -4.4pp
| Period | Period end | EBITDA Margin | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 18.0% | -4.4pp |
| FY2024 | 2024-12-31 | 22.4% | +0.7pp |
| FY2023 | 2023-12-31 | 21.7% | +1.5pp |
| FY2022 | 2022-12-31 | 20.2% | +0.2pp |
| FY2021 | 2021-12-31 | 19.9% | — |
EBITDA Margin vs competitors
How IQV compares with its peers on the latest reported figures
- IQV's LTM Jun 2026 EBITDA Margin of 20.8% is the 4th highest of the 9 companies compared; the peer median is 10.3%.
- Its year-over-year change of -0.6 pp is the 5th highest of 9, against a peer median of +0.2 pp.
- Over three fiscal years its change of -2.2 pp compares with a peer median of -6.0 pp.
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
| LTM Jul 2026 | 39.7% | +3.0 pp | +14.0 pp | |
| LTM Mar 2026 | 24.1% | +9.7 pp | -6.5 pp | |
| LTM Sep 2026 | 22.7% | -0.6 pp | +1.4 pp | |
| LTM Jun 2026 | 20.8% | -0.6 pp | -2.2 pp | |
| LTM Jun 2026 | 15.1% | -1.9 pp | -7.7 pp | |
| LTM Jun 2026 | 5.5% | -7.6 pp | -14.6 pp | |
FTREFortrea Holdings Inc. | LTM Jun 2026 | 3.0% | +34.4 pp | -39.8 pp |
| LTM Sep 2026 | -7.2% | +1.0 pp | +64.5 pp | |
| LTM Mar 2026 | -63.6% | -59.1 pp | -5.5 pp | |
| Peer median (excluding IQV) | 10.3% | +0.2 pp | -6.0 pp | |
Competitors are the stored peer set for IQV. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 13.87B | 14.41B | 14.98B | 15.41B | 16.31B |
| Cost of Revenue | 9.23B | 9.38B | 9.75B | 10.03B | 10.88B |
| Gross Profit | 4.64B | 5.03B | 5.24B | 5.38B | 5.43B |
| Gross Margin | 33.5% | 34.9% | 35.0% | 34.9% | 33.3% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 1.96B | 2.07B | 2.05B | 1.99B | 1.99B |
| Operating Expenses | 3.25B | 3.23B | 3.26B | 3.17B | 3.25B |
| Depreciation & Amortization | 1.26B | 1.13B | 1.13B | 1.11B | 640M |
| EBITDA | 2.77B | 2.91B | 3.26B | 3.45B | 2.94B |
| EBITDA Margin | 19.9% | 20.2% | 21.7% | 22.4% | 18.0% |
| Operating Income | 1.39B | 1.8B | 1.98B | 2.2B | 2.18B |
| Operating Margin | 10.0% | 12.5% | 13.2% | 14.3% | 13.4% |
| Interest Income | 6M | 13M | 36M | 47M | 45M |
| Interest Expense | 375M | 416M | 672M | 670M | 729M |
| Other Income / Expenses | (259M) | (448M) | (518M) | (533M) | (569M) |
| Income Before Tax | 1.13B | 1.35B | 1.46B | 1.67B | 1.61B |
| Pre-Tax Margin | 8.2% | 9.4% | 9.7% | 10.8% | 9.9% |
| Income Tax Expense | 163M | 260M | 101M | 296M | 252M |
| Net Income | 966M | 1.09B | 1.36B | 1.37B | 1.36B |
| Net Margin | 7.0% | 7.6% | 9.1% | 8.9% | 8.3% |
| EPS (Basic) | 5.05 | 5.82 | 7.39 | 7.57 | 7.91 |
| EPS (Diluted) | 4.95 | 5.72 | 7.29 | 7.49 | 7.84 |
| Weighted Avg Shares | 191.4M | 187.6M | 183.8M | 181.3M | 171.9M |
| Weighted Avg Shares (Diluted) | 195M | 190.6M | 186.3M | 183.4M | 173.5M |
IQVIA Holdings Inc.
NYSE:IQV
Intrinsic Alpha fair value
Locked
Current Price
$257.84
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.